Dispensing patterns of prescription-only antiobesity preparations in South Africa

Figures & data

Figure 1. Percentage gender distribition of patients according to age groups (N = 27 703)*.

* χ² = 2844.8; d.f. = 3; p < 0.0001.

Figure 2. Number of prescriptions dispensed according to age and gender (N = 52 555).

Figure 3. Seasonal variations in the dispensing of antiobesity prescriptions (N = 52 555).

Table 1: Prescribing frequency of the different antiobesity prescriptions

Active ingredients and trade names	Number of prescriptions		All patients
	Females (n = 36 521)	Males (n = 16 034)	Number (n)	%
A08AA07 - D-norpseudoephedrine (cathine)	0.07	0.06	34	0.06
Relislim^® 20 mg Tablets	0.07	0.06	34	0.06
A08AA03 – Diethylpropion (amfepramone)	0.05	0.05	26	0.05
Tenuate Dospan^® 75 mg Tablets	0.05	0.05	26	0.05
A08AB01 - Orlistat	5.48	7.45	3 197	6.08
Xenical^® 120 mg Capsules	5.48	7.45	3 197	6.08
A08AA00 - Phendimetrazine	1.37	1.35	717	1.36
Obesan X^® 35 mg Tablets	0.99	1.04	528	1.00
Obex^® 105 mg Tablets	0.38	0.31	189	0.36
A08AA01 - Phentermine	93.03	91.09	48 581	92.44
Duromine^® 15 mg Capsules	18.72	18.74	9 841	18.73
Duromine^® 30 mg Capsules	74.31	72.35	38 740	73.71
TOTAL	100.00	100.00	52 555	100.00